By Oncotarget
January 11, 2021
Behind the Study: Secretomes from metastatic breast cancer cells induce MSC actions
Researchers describe their paper published in Oncotarget titled, "Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung."... read more